WHO Issues Ebola Response Phase 3 Framework

Article

The World Health Organization (WHO) has issued the new document, Ebola Response Phase 3 Framework, to incorporate new knowledge and tools into the ongoing Ebola response and recovery work to achieve and sustain a "resilient zero." Phase 3 of the response builds upon the rapid scale-up of treatment beds, safe and dignified burial teams, and behavior change capacities during Phase 1 (August-December 2014); and the enhanced capacities for case finding, contract tracing, and community engagement during Phase 2 (January-July 2015). This framework incorporates new developments and breakthroughs in Ebola control, from vaccines, diagnostics and response operations to survivor counseling and care.

Phase 3 objectives include: Objective 1 - To accurately define and rapidly interrupt all remaining chains of Ebola transmission. Objective 2 - To identify, manage and respond to the consequences of residual Ebola risks.

The chapters include:
1. Context for the outbreak and descriptions of Objectives 1 and 2
2. Risks to the implementation of Phase 3
3. Priorities to operationalize Phase 3
4. Phase 3 and early recovery
5. Key timelines & milestones for Phase 3.

Source: WHO

Recent Videos
Ambassador Deborah L. Birx, MD, senior fellow of the George W. Bush Presidential Center
Cameron Memorial Community Hospital series with ICT  (Image Credit: CMCH)
Cameron Memorial Community Hospital series with ICT  (Image Credit: CMCH)
Cameron Memorial Community Hospital series with ICT (Image Credit: CMCH)
Cameron Memorial Community Hospital series with ICT (Image Credit: CMCH)
Cameron Memorial Community Hospital series with ICT (Image Credit: CMCH)
Isis Lamphier, MPH, MHA, CIC; Tori Whitacre Martonicz, MA; and Heather Stoltzfus, MPH, RN, CIC, at APIC Conference and Expo 2024 (Photo courtesy of Tori Whitacre Martonicz)
Lindsay K. Weir, MPH, CIC, Lead Infection Preventionist/Infection Preventionist III
•	Rebecca (Bartles) Crapanzano-Sigafoos, DrPH, MPH, CIC, FAPIC (corresponding author), executive director of APIC’s Center for Research, Practice, and Innovation, and lead author of the study.
Infection Control Today's Infection Intel: Staying Ahead With Company Updates and Product Innovations.
Related Content